Thought Leadership

The Key to Increased Sensitivity in Liquid Biopsy

Higher conversion increases data quality and accuracy of results

Written byErica Tennenhouse, PhD
| 3 min read
Register for free to listen to this article
Listen with Speechify
0:00
3:00

What are some of the benefits of liquid biopsy for cancer detection?

Liquid biopsy is sampling and analysis of saliva, blood, or other bodily fluid. Liquid biopsy enables asymptomatic screening before the patient has cancer symptoms and is a non-invasive testing method of finding cancer at the early stages. During or after treatment, a small number of cancer cells usually remain in the patient’s blood, called minimal residual disease (MRD), and can lead to relapse. Liquid biopsy and NGS can detect minute numbers of cancer cells and determine whether the treatment has completely eradicated the cancer. MRD detected by liquid biopsy can also be used to track the efficacy of treatment and adjust the therapy the patient is receiving. Compared to tissue biopsy, liquid biopsy is less invasive and therefore can be performed repeatedly over time to get a longitudinal view of cancer progression. 

To continue reading this article, sign up for FREE
Today's Clinical Lab Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.
Unlock for FREE
Add Today's Clinical Lab as a preferred source on Google

Add Today's Clinical Lab as a preferred Google source to see more of our trusted coverage.

About the Author

  • Photo portrait of Erica Tennenhouse, PhD

    Erica Tennenhouse, PhD, was the managing editor of Today's Clinical Lab (formerly Clinical Lab Manager) from 2018 to 2022. Erica is a freelance writer and has written for National Geographic, Scientific American, New Scientist, Science, and Discover.

    View Full Profile

Related Topics